A3242

Requires health insurance coverage for continuous glucose monitoring systems for glycogen storage disease treatment.

Mandates that health insurance policies and contracts provide coverage for continuous glucose monitoring systems prescribed for glycogen storage disease treatment. The coverage must be provided to the same extent as for any other medical condition. This applies to various types of health insurance policies and contracts, including those issued by medical service corporations, health maintenance organizations, and health service corporations. The requirement takes effect on the first day of the seventh month following the act's enactment.